Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for the inspection carried out by them at our API Facility at Karakhadi in the state of Gujarat during the period from May 14, 2018 to May 18, 2018.
With this, all the company’s manufacturing facilities for international markets are FDA compliant.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.
